SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022710
Filing Date
2022-11-07
Accepted
2022-11-07 17:10:48
Documents
82
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20220930.htm   iXBRL 10-Q 3073816
2 EX-31.1 axsm-ex31_1.htm EX-31.1 19354
3 EX-31.2 axsm-ex31_2.htm EX-31.2 19154
4 EX-32.1 axsm-ex32_1.htm EX-32.1 8867
5 EX-32.2 axsm-ex32_2.htm EX-32.2 8867
  Complete submission text file 0000950170-22-022710.txt   10766135

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20220930.xsd EX-101.SCH 72441
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20220930_def.xml EX-101.DEF 230558
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20220930_pre.xml EX-101.PRE 427588
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20220930_cal.xml EX-101.CAL 56654
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20220930_lab.xml EX-101.LAB 569164
76 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20220930_htm.xml XML 1931942
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 221366389
SIC: 2834 Pharmaceutical Preparations